Nils Lycke Selected Research

Glycosphingolipids

11/2020

Histo-blood group antigens of glycosphingolipids predict susceptibility of human intestinal enteroids to norovirus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nils Lycke Research Topics

Disease

18	Infections 07/2023 - 12/2002
9	Human Influenza (Influenza) 11/2022 - 11/2006
5	Inflammation (Inflammations) 07/2023 - 12/2002
2	Virus Diseases (Viral Diseases) 01/2022 - 12/2019
2	Gastritis 04/2004 - 12/2002
1	Stomach Neoplasms (Stomach Cancer) 07/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Multiple Sclerosis 01/2023
1	Autoimmune Diseases of the Nervous System 01/2023
1	Disease Progression 01/2023
1	Melanoma (Melanoma, Malignant) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Caliciviridae Infections 11/2020
1	Communicable Diseases (Infectious Diseases) 12/2019
1	Infectious Arthritis (Septic Arthritis) 01/2015
1	Synovitis 01/2015
1	Arthritis (Polyarthritis) 01/2015
1	Poliomyelitis (Polio) 07/2012
1	Rotavirus Infections 07/2012
1	Experimental Arthritis 06/2009
1	Reinfection 09/2007
1	Reproductive Tract Infections 09/2007
1	Eosinophilia 09/2004

Drug/Important Bio-Agent (IBA)

13	VaccinesIBA 01/2023 - 09/2004
9	AntigensIBA 07/2023 - 02/2008
5	Proteins (Proteins, Gene)FDA Link 07/2023 - 02/2008
5	Cholera ToxinIBA 01/2023 - 06/2009
4	Influenza Vaccines (Influenza Vaccine)FDA Link 05/2020 - 01/2006
3	AntibodiesIBA 12/2019 - 04/2004
3	Immunoglobulin A (IgA)IBA 12/2019 - 01/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2023 - 01/2015
2	Peptides (Polypeptides)IBA 01/2023 - 06/2009
2	Subunit VaccinesIBA 01/2021 - 12/2019
2	CytokinesIBA 06/2009 - 09/2004
2	Interleukin-12 (IL 12)IBA 09/2004 - 12/2002
1	Blocking AntibodiesIBA 07/2023
1	TolerogenIBA 01/2023
1	Staphylococcal Protein A (Protein A)IBA 01/2023
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2023
1	Adenosine Diphosphate (ADP)IBA 01/2022
1	Lipid NanoparticlesIBA 01/2021
1	Thymic Stromal LymphopoietinIBA 01/2021
1	InterferonsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	CarbohydratesIBA 11/2020
1	Blood Group Antigens (Blood Groups)IBA 11/2020
1	GlycosphingolipidsIBA 11/2020
1	maltodextrinIBA 05/2020
1	Viral AntigensIBA 05/2020
1	Polysaccharides (Glycans)IBA 05/2020
1	Interferon LambdaIBA 12/2019
1	Hemagglutinins (Hemagglutinin)IBA 01/2018
1	Combined VaccinesIBA 01/2018
1	Bacterial DNAIBA 01/2015
1	Cloxacillin (Tegopen)FDA Link 01/2015
1	Receptor for Advanced Glycation End ProductsIBA 01/2015
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2015
1	Toll-Like Receptor 2IBA 01/2015
1	CTA1R7K-COL-DDIBA 06/2009
1	Collagen Type II (Type II Collagen)IBA 06/2009
1	EpitopesIBA 02/2008
1	Messenger RNA (mRNA)IBA 09/2007
1	Interleukin-10 (Interleukin 10)IBA 09/2007
1	Interferon-gamma (Interferon, gamma)IBA 09/2007
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2006
1	Amino Acids FDA Link 11/2006
1	Interleukin-18 (Interleukin 18)IBA 09/2004

Therapy/Procedure

3	Intranasal Administration 01/2023 - 01/2006
2	Therapeutics 01/2023 - 01/2015
1	Injections 01/2018
1	Intra-Articular Injections 01/2015